PenderFund Capital Management Ltd. - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 3 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 7.4%.

Quarter-by-quarter ownership
PenderFund Capital Management Ltd. ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$17,187
+7.9%
13,010,000
-16.1%
5.34%
+6.8%
Q1 2023$15,930
-14.5%
15,510,0000.0%5.00%
-10.0%
Q4 2022$18,638
-99.9%
15,510,0000.0%5.56%
-9.4%
Q3 2022$19,599,000
+9.3%
15,510,000
-2.8%
6.13%
+23.7%
Q2 2022$17,925,000
-21.1%
15,960,000
-20.4%
4.96%
-10.9%
Q1 2022$22,713,000
-8.4%
20,060,000
-4.7%
5.56%
-1.2%
Q4 2021$24,802,000
+2.6%
21,060,0000.0%5.63%
-10.9%
Q3 2021$24,177,000
-1.8%
21,060,0000.0%6.32%
+9.7%
Q2 2021$24,611,000
+5.6%
21,060,000
+5.0%
5.76%
+1.8%
Q1 2021$23,311,000
+3.9%
20,060,0000.0%5.66%
-0.8%
Q4 2020$22,444,000
-0.5%
20,060,0000.0%5.71%
-9.0%
Q3 2020$22,558,000
+0.4%
20,060,0000.0%6.27%
+3.3%
Q2 2020$22,462,000
-5.1%
20,060,000
-4.7%
6.07%
-17.8%
Q1 2020$23,672,000
+61.5%
21,060,000
+35.3%
7.39%
+79.6%
Q4 2019$14,659,000
+57.6%
15,560,000
+19.1%
4.11%
+31.5%
Q3 2019$9,300,000
+49.3%
13,060,000
+44.2%
3.13%
+40.8%
Q2 2019$6,228,0009,060,0002.22%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 20,060,000$22,713,0005.56%
SILVERBACK ASSET MANAGEMENT LLC 7,707,000$6,912,0000.94%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 35,615,000$31,948,0000.74%
DeepCurrents Investment Group LLC 12,521,000$11,079,0000.34%
AGF Investments LLC 4,000,000$3,502,0000.29%
WATER ISLAND CAPITAL LLC 2,250,000$2,014,0000.10%
L & S Advisors Inc 935,000$829,0000.10%
Sculati Wealth Management, LLC 200,000$177,0000.09%
PALISADE CAPITAL MANAGEMENT, LP 3,192,000$2,816,0000.06%
Teton Advisors, Inc. 400,000$354,0000.06%
View complete list of PARATEK PHARMACEUTICALS INC shareholders